Details of the Drug

General Information of Drug (ID: DMCNFZG)

Drug Name
Anti-GD2-CAR engineered T cells
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Phase 1 [1]
Osteosarcoma 2B51 Phase 1 [1]
Sarcoma 2A60-2C35 Phase 1 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D09DND
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ganglioside GD2 (GD2) TT80ARU NOUNIPROTAC CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02107963) A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors